Ex Vivo Drug Response Profiling and Outcome Prediction in Lung Adenocarcinoma
Ex Vivo Drug Response Profiling and Outcome Prediction in Lung Adenocarcinoma
Recruiting · NCT07636252 · Registry updated 2026-06-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Ex Vivo Drug Response Profiling and Outcome Prediction in Lung Adenocarcinoma | Neoplasms by Histologic Type, Neoplasms by Site, Pleural Effusion, Pleural Effusion, Malignant, Thoracic Neoplasms, adenocarcinoma, carcinoma, epithelial neoplasm, lung adenocarcinoma, lung disorder, lung neoplasm, myeloproliferative disorder, chronic, with eosinophilia, neoplasm, pleural disorder, pleural neoplasm, respiratory system disorder, respiratory tract neoplasm | Recruiting | Not stated | 2026-06-23 | NCT07636252 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Sheba Medical Center | 63 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Sheba Medical Center | Ramat Gan | Israel | 1 |